Received Sep 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
After the vaccine patient got the dreaded Guillain Barre; paralyzed; This serious case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced guillain barre syndrome (Verbatim: After the vaccine patient got the dreaded Guillain Barre) (serious criteria hospitalization and GSK medically significant) and paralysis (Verbatim: paralyzed) (serious criteria hospitalization and GSK medically significant). The outcome of the guillain barre syndrome and paralysis were not reported. It was unknown if the reporter considered the guillain barre syndrome and paralysis to be related to RSV vaccine. The company considered the guillain barre syndrome and paralysis to be unrelated to RSV vaccine. Additional Information: GSK receipt date: 23-SEP-2025 This case was reported by a patient via interactive digital media. The patient spent the next and half months in the hospital paralyzed and came home in a wheelchair. The patient said he/she would rather have had the virus.; Sender's Comments: A case of Guillain-Barre syndrome and Paralysis, an unknown time after receiving RSV vaccine, in a patient. Based on the available information a?possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.